DrugRepV Browse Page


DrugRepV browse page allows user to take a glance of the particular antiviral agent.Fields in the webpage is hylerlinked ot various external repositories like DrugBank, PubChem, Clinicaltrials.gov,and PubMed.User can explore the biological, Clinical, Chemical, and Structural details of every repurposed drug candidate.By clicking on the table header arrows, user can sort entries in ascending or descending order.


Total number of Records for Virus inhibition assay are 21




DrugRepV_ID Antiviral Name
Drug type
Primary Indication
Secondary Indication
Strain
Pathways
Assay
Activity
Clinical Status
 References
DrugRepV_5442Naltrexone
Nervous System
Alcohol dependence
Influenza virus
A/Puerto Rico/8/34 (PR8)
Pathway
Virus inhibition assay
Decrease (5.3 log)
Approved, Investigational, Vet approved
31244822
DrugRepV_5443Gallium nitrate
NA
NA
Influenza virus
A/Puerto Rico/8/34 (PR8)
Pathway
Virus inhibition assay
Decrease (5.3 log)
Approved, Investigational
31244822
DrugRepV_5444Dextromethorphan
Respiratory System
Cough
Influenza virus
A/Puerto Rico/8/34 (PR8)
Pathway
Virus inhibition assay
Decrease (5.7 log)
Approved
31244822
DrugRepV_5445Ketotifen
Respiratory System
Atopic asthma | Conjunctivitis
Influenza virus
A/Puerto Rico/8/34 (PR8)
Pathway
Virus inhibition assay
Decrease (5.8 log)
Approved
31244822
DrugRepV_5446Naltrexone
Nervous System
Alcohol dependence
Influenza virus
pdm09A/Mexico/InDRE4487/2009
Pathway
Virus inhibition assay
Decrease (6.2 log)
Approved, Investigational, Vet approved
31244822
DrugRepV_5447Gallium nitrate
NA
NA
Influenza virus
pdm09A/Mexico/InDRE4487/2009
Pathway
Virus inhibition assay
Decrease (5.2 log)
Approved, Investigational
31244822
DrugRepV_5448Dextromethorphan
Respiratory System
Cough
Influenza virus
pdm09A/Mexico/InDRE4487/2009
Pathway
Virus inhibition assay
Decrease (5.5 log)
Approved
31244822
DrugRepV_5449Ketotifen
Respiratory System
Atopic asthma | Conjunctivitis
Influenza virus
pdm09A/Mexico/InDRE4487/2009
Pathway
Virus inhibition assay
Decrease (5.1 log)
Approved
31244822
DrugRepV_5450Naltrexone
Nervous System
Alcohol dependence
Influenza virus
A/Victoria/36/2011
Pathway
Virus inhibition assay
Decrease (5.5 log)
Approved, Investigational, Vet approved
31244822
DrugRepV_5451Gallium nitrate
NA
NA
Influenza virus
A/Victoria/36/2011
Pathway
Virus inhibition assay
Decrease (5.5 log)
Approved, Investigational
31244822
DrugRepV_5452Dextromethorphan
Respiratory System
Cough
Influenza virus
A/Victoria/36/2011
Pathway
Virus inhibition assay
Decrease (5.3 log)
Approved
31244822
DrugRepV_5453Ketotifen
Respiratory System
Atopic asthma | Conjunctivitis
Influenza virus
A/Victoria/36/2011
Pathway
Virus inhibition assay
Decrease (5.5 log)
Approved
31244822
DrugRepV_6211Mefenamic acid
Musculo-Skeletal System
Rheumatoid arthritis | Osteoarthritis | Dysmenorrhea, and mild to moderate pain, inflammation, and fever
Dengue virus
NA
Pathway
Virus inhibition assay
Decrease (50 %)
Approved
24522138
DrugRepV_6212Tolfenamic acid
Musculo-Skeletal System
Pain associated with the acute attack of migraines
Dengue virus
NA
Pathway
Virus inhibition assay
Decrease (27.6 ± 3.7 %)
Approved, Investigational
24522138
DrugRepV_6213Flufenamic Acid
Musculo-Skeletal System
Musculoskeletal | Joint disorders
Dengue virus
NA
Pathway
Virus inhibition assay
Decrease (15.2 ± 1.1 %)
Approved
24522138
DrugRepV_6214Meclofenamic acid
Musculo-Skeletal System
Pain | Primary dysmenorrhea
Dengue virus
NA
Pathway
Virus inhibition assay
Decrease (19.4 ± 2.2 %)
Approved, Vet approved
24522138
DrugRepV_6215Tetracycline
Antiinfectives For Systemic Use
Bacterial infections (Rocky Mountain spotted fever | Typhus fever | Tick fevers | Q fever | Rickettsialpox | Brill-Zinsser disease)
Dengue virus
NA
Pathway
Virus inhibition assay
Decrease (23.6 ± 2.1 %)
Approved
24522138
DrugRepV_6216Oxytetracycline
Antiinfectives For Systemic Use
Bacterial infections
Dengue virus
NA
Pathway
Virus inhibition assay
Decrease (18.8 ± 2.1 %)
Approved, Investigational, Vet approved
24522138
DrugRepV_6217Doxycycline
Antiinfectives For Systemic Use
Bacterial infections
Dengue virus
NA
Pathway
Virus inhibition assay
Decrease (50 %)
Approved
24522138
DrugRepV_6218Rolitetracycline
Antiinfectives For Systemic Use
Bacterial infection
Dengue virus
NA
Pathway
Virus inhibition assay
Decrease (32.8 ± 2.6 %)
Approved
24522138
DrugRepV_6219Ribavirin
Antiinfectives For Systemic Use
Hepatitis C virus
Dengue virus
NA
Pathway
Virus inhibition assay
Decrease (50 %)
Approved
24522138